FDMT 4D Molecular Therapeutics, Inc. Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
10:37
Feb 09
Feb 09
FDMT to 3x on catalysts
The author believes FDMT will 3x this year, citing a strong cash runway, recent growth, and an average price target of $33 versus the current $8.99. Major catalysts are expected in 2026, and the stock is seen as underpriced. The main risk is that the catalysts may not materialize or the stock may not reach the target.
HIGH
About FDMT Investor Commentary
Across the available history and selected sources, Buzzberg tracks FDMT (4D Molecular Therapeutics, Inc.) across 1 sources: 1 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 100% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 1 total trade idea tracked. Latest voices: u/Living_Dinner3163.